Tue, Sep 16, 2014, 1:12 AM EDT - U.S. Markets open in 8 hrs 18 mins

Recent

% | $
Quotes you view appear here for quick access.

Elan Corporation, plc Message Board

  • bidatthe_bell bidatthe_bell Mar 21, 2003 12:42 AM Flag

    WFHC -70% ELN OWNS 6%

    -----------
    Johnson and Johnson controlled WFHC is a historically profitable senior Drug company with over $40 MM in annual sales to women over 40 and was $10 a year ago. WFHC dropped from $1.78 to $.63 on bad earnings, but is streamlining and forecasts RETURN TO PROFIT THIS YEAR.

    Fundamental and technical reasons WFHC a GREAT buy:
    Fundamental:
    -Big drug companies, Elan and Johnson and Johnson own BIG pieces of WFHC.
    -WFHC historically very profitable- great niche market, middle age women.
    -Slashing costs, RETURN TO PROFIT this year.

    Technical
    -$.60 held firm in wake of MASSIVE selling. WFHC has hit Bottom.
    -Tiny 12 Million float. WFHC will rise VERY fast.

    Folks, this is no "R+D" drug company like LJPC: it has $40 MM + in sales, a GREAT product pipeline, backing from the drug giants and is getting its house in order again for returned PROFITS.
    Short term no brainer 50%-100% gain.

    Equity: Common Stock $.001 Par, 11/02, 40M auth., 22,949,381 o/s, net of shares in Treas. @ cost. Insiders control approx. 32% (incl. 300K options). Johnson & Johnson Development Corp. owns 8%. Elan Pharma owns 6%. IPO 6/29/99, 4.5M shares @ $11 by Allen & Company. Private Placement 08/09/01, 3.5M shares @ $9 by the Company.

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
JDS Uniphase Corporation
NasdaqGSMon, Sep 15, 2014 4:15 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT